BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 19694115)

  • 21. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
    Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J;
    Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
    Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
    Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
    J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting.
    Chapuis PH; Bokey EL; Clarke S; Beale P; Dent OF
    ANZ J Surg; 2009 Oct; 79(10):685-92. PubMed ID: 19878161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).
    Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A
    Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
    Biondo S; Martí-Ragué J; Kreisler E; Parés D; Martín A; Navarro M; Pareja L; Jaurrieta E
    Am J Surg; 2005 Apr; 189(4):377-83. PubMed ID: 15820446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
    Winget M; Hossain S; Yasui Y; Scarfe A
    Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
    Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.
    Moore J; Hyman N; Callas P; Littenberg B
    Surgery; 2010 Mar; 147(3):358-65. PubMed ID: 19962166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival.
    Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1353-60. PubMed ID: 16765531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based study of prognostic factors in stage II colonic cancer.
    Morris M; Platell C; de Boer B; McCaul K; Iacopetta B
    Br J Surg; 2006 Jul; 93(7):866-71. PubMed ID: 16622901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
    Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
    J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
    Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
    Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
    Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM
    Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.